292 related articles for article (PubMed ID: 31498687)
1. Proton pump inhibitors, adverse events and increased risk of mortality.
Lanas-Gimeno A; Hijos G; Lanas Á
Expert Opin Drug Saf; 2019 Nov; 18(11):1043-1053. PubMed ID: 31498687
[No Abstract] [Full Text] [Related]
2. Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study.
Xie Y; Bowe B; Yan Y; Xian H; Li T; Al-Aly Z
BMJ; 2019 May; 365():l1580. PubMed ID: 31147311
[TBL] [Abstract][Full Text] [Related]
3. Do proton pump inhibitors increase mortality? A systematic review and in-depth analysis of the evidence.
Ben-Eltriki M; Green CJ; Maclure M; Musini V; Bassett KL; Wright JM
Pharmacol Res Perspect; 2020 Oct; 8(5):e00651. PubMed ID: 32996701
[TBL] [Abstract][Full Text] [Related]
4. Adverse Events of Proton Pump Inhibitors: Potential Mechanisms.
Corsonello A; Lattanzio F; Bustacchini S; Garasto S; Cozza A; Schepisi R; Lenci F; Luciani F; Maggio MG; Ticinesi A; Butto V; Tagliaferri S; Corica F
Curr Drug Metab; 2018; 19(2):142-154. PubMed ID: 29219052
[TBL] [Abstract][Full Text] [Related]
5. Indications and safety of proton pump inhibitor drug use in patients with cancer.
Triadafilopoulos G; Roorda AK; Akiyama J
Expert Opin Drug Saf; 2013 Sep; 12(5):659-72. PubMed ID: 23647006
[TBL] [Abstract][Full Text] [Related]
6. [What is the REAL long-term risk of proton pump inhibitors?].
Ribiere S; Guillaumot MA; Barré A; Abou Ali E; Barret M; Chaussade S; Coriat R
Presse Med; 2019 May; 48(5):503-510. PubMed ID: 30926204
[TBL] [Abstract][Full Text] [Related]
7. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
Freedberg DE; Kim LS; Yang YX
Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
[TBL] [Abstract][Full Text] [Related]
8. Inappropriate Use of Proton Pump Inhibitor Among Elderly Patients in British Columbia: What are the Long-term Adverse Events?
Ben-Eltriki M; Chhabra M; Cassels A; Wright JM
Curr Drug Saf; 2024; 19(2):244-247. PubMed ID: 37496243
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and non-cardiovascular concerns with proton pump inhibitors: Are they safe?
Corsonello A; Lattanzio F
Trends Cardiovasc Med; 2019 Aug; 29(6):353-360. PubMed ID: 30389278
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors and cardiovascular adverse effects: Real or surreal worries?
Manolis AA; Manolis TA; Melita H; Katsiki N; Manolis AS
Eur J Intern Med; 2020 Feb; 72():15-26. PubMed ID: 31796246
[TBL] [Abstract][Full Text] [Related]
11. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome.
Singh A; Cresci GA; Kirby DF
Nutr Clin Pract; 2018 Oct; 33(5):614-624. PubMed ID: 30071147
[TBL] [Abstract][Full Text] [Related]
12. Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva.
de la Coba Ortiz C; Argüelles Arias F; Martín de Argila de Prados C; Júdez Gutiérrez J; Linares Rodríguez A; Ortega Alonso A; Rodríguez de Santiago E; Rodríguez-Téllez M; Vera Mendoza MI; Aguilera Castro L; Álvarez Sánchez Á; Andrade Bellido RJ; Bao Pérez F; Castro Fernández M; Giganto Tomé F
Rev Esp Enferm Dig; 2016 Apr; 108(4):207-24. PubMed ID: 27034082
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors: Risks of long-term use.
Eusebi LH; Rabitti S; Artesiani ML; Gelli D; Montagnani M; Zagari RM; Bazzoli F
J Gastroenterol Hepatol; 2017 Jul; 32(7):1295-1302. PubMed ID: 28092694
[TBL] [Abstract][Full Text] [Related]
14. The Association Between Proton Pump Inhibitor Use With Acute Kidney Injury and Chronic Kidney Disease.
Kamal F; Khan MA; Molnar MZ; Howden CW
J Clin Gastroenterol; 2018 Jul; 52(6):468-476. PubMed ID: 29668562
[TBL] [Abstract][Full Text] [Related]
15. Is the concomitant use of clopidogrel and Proton Pump Inhibitors still associated with increased adverse cardiovascular outcomes following coronary angioplasty?: a systematic review and meta-analysis of recently published studies (2012 - 2016).
Bundhun PK; Teeluck AR; Bhurtu A; Huang WQ
BMC Cardiovasc Disord; 2017 Jan; 17(1):3. PubMed ID: 28056809
[TBL] [Abstract][Full Text] [Related]
16. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.
Kwok CS; Jeevanantham V; Dawn B; Loke YK
Int J Cardiol; 2013 Aug; 167(3):965-74. PubMed ID: 22464478
[TBL] [Abstract][Full Text] [Related]
17. Proton Pump Inhibitors, Kidney Damage, and Mortality: An Updated Narrative Review.
Edinoff AN; Wu NW; Parker K; Dudossat E; Linquest L; Flanagan CJ; Dharani A; Patel H; Willett O; Cornett EM; Kaye AM; Kaye AD
Adv Ther; 2023 Jun; 40(6):2693-2709. PubMed ID: 37140707
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
Fortuna LA; Pawloski PA; Parker ED; Trower NK; Kottke TE
Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):13-9. PubMed ID: 27533057
[TBL] [Abstract][Full Text] [Related]
19. Proton Pump Inhibitors: Review of Emerging Concerns.
Nehra AK; Alexander JA; Loftus CG; Nehra V
Mayo Clin Proc; 2018 Feb; 93(2):240-246. PubMed ID: 29406201
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors are associated with increased risk of development of chronic kidney disease.
Arora P; Gupta A; Golzy M; Patel N; Carter RL; Jalal K; Lohr JW
BMC Nephrol; 2016 Aug; 17(1):112. PubMed ID: 27487959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
